Bionik Laboratories (OTCMKTS:BNKL – Get Free Report) and ReWalk Robotics (NASDAQ:LFWD – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, institutional ownership, profitability and earnings.
Earnings & Valuation
This table compares Bionik Laboratories and ReWalk Robotics”s top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Bionik Laboratories | $1.80 million | 0.00 | -$4.95 million | N/A | N/A |
ReWalk Robotics | $13.85 million | 1.05 | -$22.13 million | ($2.49) | -0.66 |
Bionik Laboratories has higher earnings, but lower revenue than ReWalk Robotics.
Profitability
Net Margins | Return on Equity | Return on Assets | |
Bionik Laboratories | N/A | N/A | N/A |
ReWalk Robotics | -77.21% | -43.02% | -31.53% |
Risk & Volatility
Bionik Laboratories has a beta of -1.36, meaning that its share price is 236% less volatile than the S&P 500. Comparatively, ReWalk Robotics has a beta of 2.04, meaning that its share price is 104% more volatile than the S&P 500.
Analyst Ratings
This is a breakdown of current recommendations for Bionik Laboratories and ReWalk Robotics, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Bionik Laboratories | 0 | 0 | 0 | 0 | 0.00 |
ReWalk Robotics | 0 | 0 | 1 | 1 | 3.50 |
ReWalk Robotics has a consensus target price of $13.00, indicating a potential upside of 687.88%. Given ReWalk Robotics’ stronger consensus rating and higher probable upside, analysts plainly believe ReWalk Robotics is more favorable than Bionik Laboratories.
Institutional and Insider Ownership
26.8% of ReWalk Robotics shares are held by institutional investors. 34.7% of Bionik Laboratories shares are held by insiders. Comparatively, 2.5% of ReWalk Robotics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
ReWalk Robotics beats Bionik Laboratories on 7 of the 12 factors compared between the two stocks.
About Bionik Laboratories
Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.
About ReWalk Robotics
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.
Receive News & Ratings for Bionik Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionik Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.